Jump Financial’s Apollo Endosurgery, Inc. APEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-25,167
Closed -$250K 2290
2023
Q1
$250K Sell
25,167
-10,415
-29% -$103K 0.01% 1206
2022
Q4
$355K Buy
35,582
+24,382
+218% +$182K 0.02% 945
2022
Q3
$62K Buy
+11,200
New +$62.1K ﹤0.01% 1488
2022
Q1
Sell
-17,626
Closed -$149K 2040
2021
Q4
$149K Sell
17,626
-2,474
-12% -$21.6K 0.01% 1164
2021
Q3
$182K Buy
+20,100
New +$173K 0.01% 892

Jump Financial's APEN Position: Q2 2023 in Review

Jump Financial sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 25,167 shares — an estimated $250K sold.

Jump Financial first reported a position in APEN in Q3 2021 and held it in 5 quarters. The position peaked at $355K in Q4 2022. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

  • Jump Financial reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
  • Jump Financial sold 25,167 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $250K.
  • Jump Financial first reported a position in Apollo Endosurgery, Inc. in Q3 2021 and held it in 5 quarters.
  • Jump Financial's Apollo Endosurgery, Inc. position peaked at $355K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Jump Financial's 13F filing for Q2 2023, filed 7 Aug 2023.